Together, they promote fat metabolism, improve energy, and support liver function
Improved insulin sensitivity: Research indicates GLP-1 agonists improve how cells respond to insulin, independent of weight loss
In April 2025, according to an article published by the Heart Rhythm Society, a recent clinical study, TRANSFORM-AF, found that GLP-1 receptor agonists (GLP-1 RAs), typically used for diabetes, may reduce atrial fibrillation (AF)-related events in patients with both obesity and AF
Surgeons now individualize every single treatment plan to fit your specific physiological needs
Extended room temperature exposure of 24 hours or more means you should discard the vial
GLP-1: Which Appetite Approach Fits You